Healthy Skepticism Library item: 15216
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Synexus extends patient outreach through GP sales force
Synexus 2009 Feb 5
http://www.synexus.co.uk/news--media/news/synexus-extends-patient-outreach-through-gp-sales-force.aspx
Full text:
Synexus has extended its ability to find more patients to take part in clinical trials in the UK through the launch of a GP practice sales force.
The sales force, initially comprising five clinical trial experts, will call on GPs surrounding the seven Synexus clinical sites in the UK. GPs are keen to be involved with clinical trials but lack the time and increasingly the specialised equipment now required in many trials. This partnership with Synexus allows them to become involved in the latest treatments whilst not compromising on their service to their own patients.
Synexus, who is a world leader in the recruitment of patients into clinical trials at its own research centres in Europe, Africa and Asia, is looking at rolling this out across its sites in Europe.
Synexus who recently found more than three thousand patients for a single study is developing a range of sophisticated tools to talk to patients about taking part in clinical trials.
Michael Fort, Chief Executive of Synexus, explains “The Synexus model of having our own clinical sites which are staffed by full time trained investigators has led to a huge demand for our services from pharma, bios and CROs. This new development of extending our outreach to GPs through this partnership agreement is just one of several new initiatives we are putting in place to reach patients”.
- ENDS –
Notes to editors:
Synexus® headquartered in Manchester, England, is the world’s largest multi-national company dedicated to the recruitment and running of late stage clinical trials by full time GCP trained investigators at its own clinical trial sites.Synexus® recruits participants for clinical trials on behalf of pharmaceutical, biotech and CROs. The clinical trials are then run and managed by Synexus® at 16 sites across the UK, Poland, Hungary, Bulgaria, India and South Africa.
Synexus® currently has more than ten thousand patients enrolled in clinical trials.
